GNH USA

Europe — EMA

Mitoxantrona Sandoz (Mitoxantrone)

GNH USA supplies Mitoxantrona Sandoz (Mitoxantrone), an anthracenedione for acute leukemias, metastatic breast cancer and prostate cancer. Request a quote.

Mitoxantrone

Request sourcing

1
Pack/s

What is Mitoxantrone?

Mitoxantrone, the active ingredient in Mitoxantrona Sandoz, is an anthracenedone presented as an injectable solution for intravenous use. It is employed in the treatment of acute myeloid leukemia, acute lymphoblastic leukemia, metastatic breast cancer, prostate cancer and multiple sclerosis in adult patients, and is indicated for use under specialist supervision.

GNH USA supplies Mitoxantrona Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, transplant units and pharmacies worldwide, with robust quality‑assurance processes and cold‑chain logistics today.

What is Mitoxantrone used for?

Mitoxantrone is used in oncology and hematology to target rapidly proliferating malignant cells.

Acute myeloid leukemia: induces remission by reducing leukemic blast counts. Acute lymphoblastic leukemia: helps achieve complete remission in refractory cases. Metastatic breast cancer: slows disease progression and improves survival. Prostate cancer: used in hormone‑refractory disease to control tumor growth. Multiple sclerosis: administered to reduce disease activity in severe, progressive forms.

What are the side effects of Mitoxantrone?

Common Side Effects: - Nausea and vomiting. - Fatigue and weakness. - Alopecia (hair loss). - Myelosuppression leading to low blood counts. - Mild hepatic enzyme elevations.

Serious or Rare Side Effects: - Cardiotoxicity, including reduced left ventricular ejection fraction. - Secondary acute leukemia. - Severe infections due to profound neutropenia. - Pulmonary toxicity such as interstitial pneumonitis. - Hepatic failure or severe transaminase elevation.

What precautions apply to Mitoxantrone?

Mitoxantrona Sandoz requires careful monitoring and patient selection.

Blood count monitoring: perform complete blood counts regularly to detect myelosuppression. Cardiac function assessment: obtain baseline and periodic echocardiograms to evaluate left ventricular function. Liver function monitoring: check hepatic enzymes before and during therapy. Pregnancy avoidance: contraindicated in pregnancy due to fetal risk; use effective contraception. Renal function evaluation: adjust therapy in patients with impaired renal clearance. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Mitoxantrone interact with?

Mitoxantrona Sandoz may interact with several drug classes.

Major Interactions (Avoid): - Concurrent use with other cardiotoxic agents: may increase risk of cardiac damage. - Live vaccines: immunosuppression can reduce vaccine efficacy. - Strong CYP2C8 inhibitors: may raise plasma mitoxantrone concentrations.

Moderate Interactions (Monitor Closely): - Other myelosuppressive chemotherapy: monitor blood counts closely. - Anticoagulants: may increase bleeding tendency.

Frequently asked questions

What is Mitoxantrona Sandoz used for?+
Mitoxantrona Sandoz contains mitoxantrone, an antineoplastic agent indicated for the treatment of acute myeloid leukemia, acute lymphoblastic leukemia, metastatic breast cancer, hormone‑refractory prostate cancer, and severe forms of multiple sclerosis.
How does mitoxantrone work?+
Mitoxantrone intercalates into DNA and stabilizes the topoisomerase II‑DNA complex, preventing the re‑ligation of DNA strands during replication. This creates double‑strand breaks, halting cell division and triggering apoptosis in rapidly dividing malignant or immune cells.
What is the usual dose of Mitoxantrona Sandoz?+
The dose of Mitoxantrona Sandoz is individualized by the prescribing physician based on the specific indication, disease severity, patient weight, renal and hepatic function, and prior treatment history. No fixed regimen is provided here.
Is Mitoxantrona Sandoz safe during pregnancy or breastfeeding?+
Mitoxantrona Sandoz is classified as Pregnancy Category D, indicating evidence of fetal risk. It should be avoided in pregnant women and not used while breastfeeding because it can be excreted in milk and may harm the infant.
How do I order Mitoxantrona Sandoz from GNH USA?+
To order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.
How does Mitoxantrona Sandoz compare with other anthracenedones or alternative drugs?+
Mitoxantrona Sandoz offers a similar DNA‑intercalating mechanism to other anthracenedones but differs in its pharmacokinetic profile and approved indications. Compared with agents such as doxorubicin, mitoxantrone has a lower incidence of acute cardiotoxicity at equivalent doses, though long‑term monitoring remains essential.
How should Mitoxantrona Sandoz be stored and handled?+
The product must be stored refrigerated at 2‑8 °C, protected from light, and should never be frozen or shaken. Use aseptic technique when preparing the injectable solution, and keep the vial in its original packaging until use.
How is Mitoxantrona Sandoz administered?+
Mitoxantrona Sandoz is supplied as an injectable solution for intravenous infusion. Administration is performed by a qualified healthcare professional, typically over a period of 30‑60 minutes, with dosing calculated by the treating physician.
What are the most serious risks to watch for with Mitoxantrona Sandoz?+
Serious risks include cardiotoxicity (reduced left‑ventricular function), secondary acute leukemia, severe infections due to neutropenia, pulmonary toxicity such as interstitial pneumonitis, and hepatic failure. Patients should be monitored closely for these events throughout therapy.
Who should not use Mitoxantrona Sandoz?+
Mitoxantrona Sandoz is contraindicated in patients with known hypersensitivity to mitoxantrone or any formulation component, in pregnant women, and in individuals with pre‑existing severe cardiac disease, uncontrolled infections, or significant hepatic impairment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Mitoxantrone
Route
Intravenous Use
Manufacturer
Sandoz Farmacêutica Lda.
Origin
EU

Related products

Mitoxan

Mitoxan

Mitoxantrone

Medicamerc S.A
EU
Mitoxantron "ebewe"

Mitoxantron "ebewe"

Mitoxantrone

Ebewe Pharma
EU
Mitoxantron Accord

Mitoxantron Accord

Mitoxantrone

Accord Healthcare B.V.
EU
Mitoxantron Ebewe

Mitoxantron Ebewe

Mitoxantrone

Ebewe Pharma
EU